Johnson & Johnson Profile Avatar - Palmy Investing

Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby br…
Drug Manufacturers - General
US, New Brunswick [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
16,571.00 16,385.00 14,298.00 15,396.00 17,414.00 18,471.00 19,279.00 18,767.00 21,056.00 22,201.00 23,416.00 23,536.00 23,410.00 21,194.00 22,791.00
Operating Cash (Net)
16,571.00 16,385.00 14,298.00 15,396.00 17,414.00 18,471.00 19,279.00 18,767.00 21,056.00 22,201.00 23,416.00 23,536.00 23,410.00 21,194.00 22,791.00
Accounts Receivable
453.00 -207.00 -915.00 -9.00 -632.00 -247.00 -433.00 -1,065.00 -633.00 -1,185.00 -289.00 774.00 -2,402.00 -1,290.00 -624.00
Accounts Payable
-507.00 20.00 493.00 -23,813.00 -30,419.00 -33,925.00 -30,242.00 -39,204.00 2,725.00 -12,971.00 4,060.00 5,141.00 2,437.00 1,098.00 2,346.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-7,598.00 -7,854.00 -4,612.00 -4,510.00 -5,103.00 -12,305.00 -7,735.00 -4,761.00 -14,868.00 -3,167.00 -6,194.00 -20,825.00 -8,683.00 -12,371.00 878.00
Capital Expenditure
-2,365.00 -2,384.00 -2,893.00 -2,934.00 -3,595.00 -3,714.00 -3,463.00 -3,226.00 -3,279.00 -3,670.00 -3,498.00 -3,347.00 -3,652.00 -4,009.00 -4,543.00
Purchases of Investments
-10,040.00 -15,788.00 -29,882.00 -13,434.00 -18,923.00 -34,913.00 -40,828.00 -33,950.00 -6,153.00 -5,626.00 -3,920.00 -21,089.00 -30,394.00 -32,384.00 -10,906.00
Sale/Maturity of Investment
7,232.00 11,101.00 30,396.00 14,797.00 18,058.00 24,119.00 34,149.00 35,780.00 28,117.00 4,289.00 3,725.00 12,137.00 25,006.00 41,609.00 19,390.00
Property, Plant, Equipment (P&PE)
-2,365.00 -2,384.00 -2,893.00 -2,934.00 -3,595.00 -3,714.00 -3,463.00 -3,226.00 -3,279.00 -3,670.00 -3,498.00 -3,347.00 -3,652.00 -4,009.00 -4,543.00
Acquisitions (Net)
-2,470.00 -1,269.00 -2,797.00 -4,486.00 -835.00 -2,129.00 -954.00 -4,509.00 -35,151.00 -899.00 -5,810.00 -7,323.00 -60.00 -17,652.00 358.00
Other Investing Activities
45.00 486.00 564.00 1,547.00 192.00 4,332.00 3,361.00 1,144.00 1,598.00 2,739.00 3,309.00 -1,203.00 417.00 65.00 -3,421.00
Financing Activities
Used Cash (Net)
-4,092.00 -4,980.00 -4,452.00 -20,562.00 -6,091.00 -12,260.00 -10,846.00 -8,551.00 -7,673.00 -18,510.00 -18,015.00 -6,120.00 -14,047.00 -8,871.00 -15,825.00
Debt Repayment
-7,010.00 -6,597.00 -11,216.00 -6,979.00 -2,990.00 -3,111.00 -1,112.00 -4,240.00 -3,107.00 -4,034.00 -2,923.00 -3,727.00 -2,992.00 -8,684.00 -10,781.00
Dividends Paid
-5,327.00 -5,804.00 -6,156.00 -6,614.00 -7,286.00 -7,768.00 -8,173.00 -8,621.00 -8,943.00 -9,494.00 -9,917.00 -10,481.00 -11,032.00 -11,682.00 -11,770.00
Common Stock
2,130 2,797 2,525 18,952 11,205 7,124 9,076 22,283 17,281 6,902 7,742 15,157 6,494 7,364 18,436
Other Financing Activities
10,375.00 10,218.00 15,445.00 -83.00 56.00 5,743.00 -57.00 -15.00 -188.00 -148.00 575.00 -627.00 395.00 16,201.00 -1,602.00
Cash Balances
Begin of Period
10,768.00 15,810.00 19,355.00 24,542.00 14,911.00 20,927.00 14,523.00 13,732.00 18,972.00 17,824.00 18,107.00 17,305.00 13,985.00 14,487.00 12,889.00
End of Period
15,810.00 19,355.00 24,542.00 14,911.00 20,927.00 14,523.00 13,732.00 18,972.00 17,824.00 18,107.00 17,305.00 13,985.00 14,487.00 14,127.00 21,859.00
Change
5,042.00 3,545.00 5,187.00 -9,631.00 6,016.00 -6,404.00 -791.00 5,240.00 -1,148.00 283.00 -802.00 -3,320.00 502.00 -360.00 8,970.00
Non-Cash Balances
Depreciation and Amortization
2,774.00 2,939.00 3,158.00 3,666.00 4,104.00 3,895.00 3,746.00 3,754.00 5,642.00 6,929.00 7,009.00 7,231.00 7,390.00 6,970.00 7,486.00
Stock Based Compensation
628.00 614.00 621.00 662.00 728.00 792.00 874.00 878.00 962.00 978.00 977.00 1,005.00 1,135.00 1,138.00 1,162.00
Other
58.00 12.00 32.00 2,562.00 299.00 -1,914.00 -1,819.00 -291.00 -495.00 10.00 -1,078.00 -963.00 324.00 819.00 2,504.00
Highlighted metrics
Free Cash Flow (FCF)
14,206.00 14,001.00 11,405.00 12,462.00 13,819.00 14,757.00 15,816.00 15,541.00 17,777.00 18,531.00 19,918.00 20,189.00 19,758.00 17,185.00 18,248.00
Cash Conversion Cycle (CCC)
49.00 53.00 69.00 89.00 86.00 62.00 79.00 80.00 85.00 77.00 70.00 57.00 51.00 71.00 84.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of JNJ's Analysis
CIK: 200406 CUSIP: 478160104 ISIN: US4781601046 LEI: - UEI: -
Secondary Listings